期刊文献+

女性膀胱癌的临床病理特征分析 被引量:1

The clinicopathological characteristics of bladder cancer in the female
下载PDF
导出
摘要 目的探讨女性膀胱癌的临床病理特点。方法回顾分析2000年7月~2011年8月163例女性初发膀胱尿路上皮癌患者的临床病理资料,根据发病年龄分为〈40岁,40~59岁,60~79岁,≥80岁4组,分别对各组的临床分期、病理分级、治疗方式等方面进行统计学分析。结果各年龄段的膀胱癌的病理分期构成比差异无统计学意义(P=0.07)。各年龄段高级别尿路上皮癌构成比分别为9.1%、17.9%、37.9%、61.1%,各年龄段的膀胱尿路上皮癌的病理分级构成比差异有统计学意义(P=0.002)。各年龄段的膀胱尿路上皮癌手术方式构成比差异无统计学意义(P=0.5)。结论膀胱癌主要发生在围绝经期的女性,女性膀胱癌不同的年龄人群具有不同的临床病理特征,这些特征对治疗方案和疾病预后均有指导意义。 Objective To determine the clinicopathological characteristics of bladder cancer in the female. Methods From Jul 2000 to Aug 2011, the clinical data of 163 female patients with bladder cancer was retrospectively reviewed. According to their age, the patients were classified into four groups: 〈40 years group,40-59 years group,60-79 years group,≥ 80 years group.The four groups were evaluated for clinical stages, pathological grades and treatment. Results There was no statistically difference in the stage among the four groups (P=0.07).The percentage of high pathologic grades in the four groups were:9.1%, 17.9% ,37.9% ,61.1% ,respectively, there was statistically significant difference among the four groups (P=O.OO2).There was no statistically difference in the treatment among the four groups (P=0.5). Conclusion Bladder cancer mainly occurs in the premenopausal women. Different age groups have different clinicopathological characteristics. These features have instructively suggestion on the treatment and prognosis.
出处 《中国现代医药杂志》 2012年第2期14-16,共3页 Modern Medicine Journal of China
关键词 膀胱癌 年龄 女性 移行细胞癌 吸烟 Bladder cancer Age Female Transitional cell carcinoma Smoke
  • 相关文献

参考文献10

  • 1Jemal A,Siegel R,Ward E,et al.Cancer Statistics[J].CA Cancer J Clin,2009,59:225-249.
  • 2Parag Gupta,Manoj Jain,Rakesh Kapoor,et al.Impact of age and gender on the clinicopathological characteristics of bladder cancer[J].Indian J Urol,2009,25(2):207-210.
  • 3Burch JD,Rohan TE,Howe GR,et al.Risk of bladder cancer by source and type of tobacco exposure:A case-control study[J].Int J Cancer,1989,44:622-628.
  • 4Carmen J.Marsit,E.Andres Houseman,Alan R.Schned,et al.Pro-moter hypermethylation is associated with current smoking,age,gender and survival in bladder cancer[J].Carcinogenesis,2007:1745-1751.
  • 5Prior JC.Perimenopause:the complex endocrinology of the meno-pausal transition.Endocrinol[J].Endocr Rev,1998,19(4):397-428.
  • 6Pelletier G.Localization of androgen and estrogen receptors in rat and primate tissues[J].Histol Histopathol,2000,15:1261-1270.
  • 7Makela S,Strauss L,Kuiper G,et al.Differential expression of es-trogen receptors alpha and beta in adult rat accessory sex glands and lower urinary tract[J].Mol Cell Endocrinol,2000,170:219-229.
  • 8Saez S,Martin PM.Evidence of estrogen receptors in the trigone area of human urinary bladder[J].J Steroid Biochem,1981,15:317-320.
  • 9An-Tsun Huang,Manolis Kogevinas,Debra T,et al.Bladder cancer and reproductive factors among women in Spain[J].Can-cer Causes Control,2009,20:1907-1913.
  • 10Shariat SF,Karakiewicz PI,Palapattu GS,et al.Outcomes of radi-cal cystectomy for transitional cell carcinoma of the bladder:a contemporary series from the bladder cancer research consortium[J].J Urol,2006,176:2414-2422.

同被引文献16

  • 1sKnoblach T, Grandel B, Seiler, et al. Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activiated STAT1 but not interferon 7 [J]. PloS Pathog, 2011, 7(4): e1002016.
  • 2Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, et al. ldenti fication of viral infeeions in the prostate and evaluation of their as sociation with cancer[J]. BMC Can, 2010, 24(10): 326.
  • 3MO W, Sylvester R. Eauguidelines on nonmuscle carcinoma of the bladder[J]. EAU Guidelines, 2009, 33(4): 361-71.
  • 4Smuc T, Ahn I Y, Ulrich H. Nucleic acid aptamers as high affin ity ligands in biotechnology and biosensorics[J]. J Pharm Biomed Anal, 2013, 81/82, 210-7.
  • 5James ND, Hussain SA, Hall E, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer[J]. N Engl J Med, 2012, 366(16): 1477-88.
  • 6Correa CB, Kouri V, Verdasquera D, et al. HCMV seropreva lence and associated risk factors in pregnant women in Havana City from 2007 1o 2008[J]. Prenat Diagn, 2010, 30(9): 888- 92.
  • 7Jemal A, Siege 1R, Xu J, et al. Cancer stalislics[J]. CA Cancer J Clin, 2010, 60(5): 277 -300.
  • 8Zawiliriska B, Szostek S, Kope J, et al. ML55 genotype diversi ty of eytomegalovirus strains isolated from newborns and infants hospitalized in southern Poland[J]. Przegl Epidcmiol, 2011, 65 (3): 409-13.
  • 9Green DA, Rink M, Hansen J, et al. Accurate preoperative prediction of non-organ-congined bladder urothelial carcinoma at custectomy[J]. BJU Int, 2012, 11(3): 182-9.
  • 10付伟伟,董涛.上尿路上皮癌临床诊断方法分析[J].齐鲁医学杂志,2008,23(1):33-34. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部